We are live on ! Find out more
PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
DCM
1
DAFNA Capital Management
California
$9.69K
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$4K
HLA
3
Hamilton Lane Advisors
Pennsylvania
$1K +$5.61K +34,208 New
IIA
4
IPG Investment Advisors
California
$864
Barclays
5
Barclays
United Kingdom
$6
NMC
6
NEA Management Company
Maryland
-$1.17M -6,643,702 Closed
APM
7
Avidity Partners Management
Texas
-$768K -4,361,365 Closed
RSCM
8
Rock Springs Capital Management
Maryland
-$479K -2,719,074 Closed
MCM
9
MAI Capital Management
Ohio
-$406K -2,307,534 Closed
Vanguard Group
10
Vanguard Group
Pennsylvania
-$318K -1,808,098 Closed
JJ
11
Johnson & Johnson
New Jersey
-$283K -1,607,044 Closed
BlackRock
12
BlackRock
New York
-$116K -665,563 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
-$56K -320,642 Closed
PTP
14
Platform Technology Partners
New York
-$41K -231,900 Closed
BCM
15
Bridgeway Capital Management
Texas
-$35K -201,600 Closed
OIA
16
OneDigital Investment Advisors
Kansas
-$30K -171,150 Closed
Jane Street
17
Jane Street
New York
-$19K -110,661 Closed
Morgan Stanley
18
Morgan Stanley
New York
-$17K -95,763 Closed
State Street
19
State Street
Massachusetts
-$16K -91,850 Closed
SCA
20
Snowden Capital Advisors
New York
-$10K -60,800 Closed
Northern Trust
21
Northern Trust
Illinois
-$10K -58,119 Closed
NFC
22
Northeast Financial Consultants
Connecticut
-$7K -37,760 Closed
UBV
23
United Bank (Virginia)
Virginia
-$7K -37,400 Closed
William Blair & Company
24
William Blair & Company
Illinois
-$6K -35,696 Closed
RJA
25
Raymond James & Associates
Florida
-$3K -15,500 Closed